Related Experiment Video
Updated: Jun 13, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
[Diabetes and cardiovascular disease in NIPPON DATA]
Aya Kadota1, Katsuyuki Miura, Hirotsugu Ueshima
1Department of Health Science, Shiga University of Medical Science.
Summary
Diabetes mellitus significantly increases cardiovascular disease (CVD) mortality risk, even at pre-diabetic levels. Managing diabetes is crucial for preventing CVD, especially within metabolic syndrome contexts.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a growing global health concern.
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- The interplay between diabetes, metabolic syndrome, and CVD risk requires further investigation.
Purpose of the Study:
- To investigate the impact of diabetes mellitus on cardiovascular disease (CVD) mortality in a Japanese cohort.
- To assess CVD mortality risks associated with diabetes and metabolic syndrome.
- To understand the role of diabetes in exacerbating CVD risk within metabolic syndrome.
Main Methods:
- Analysis of the NIPPON DATA cohort study.
- Calculation of hazard ratios (HRs) for CVD and coronary heart disease mortality.
- Comparison of CVD mortality between diabetic and non-diabetic participants, including those with and without metabolic syndrome.
Main Results:
- Diabetes mellitus was associated with a nearly two-fold increased hazard ratio for CVD and coronary heart disease mortality.
- Elevated CVD risk was observed even in participants below established diabetes thresholds.
- Diabetic participants exhibited a higher prevalence of other metabolic risk factors.
- Metabolic syndrome with diabetes showed a substantially higher CVD mortality (HR, 3.67) compared to metabolic syndrome without diabetes (HR, 1.61).
Conclusions:
- Diabetes mellitus significantly contributes to cardiovascular disease mortality, particularly in the context of metabolic syndrome.
- Early identification and management of diabetes and associated metabolic risk factors are critical for CVD prevention.
- Interventions targeting diabetic status progression are essential for reducing the burden of CVD.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...